ZA926241B - Dosage form for delivering drug in short-time period - Google Patents
Dosage form for delivering drug in short-time periodInfo
- Publication number
- ZA926241B ZA926241B ZA926241A ZA926241A ZA926241B ZA 926241 B ZA926241 B ZA 926241B ZA 926241 A ZA926241 A ZA 926241A ZA 926241 A ZA926241 A ZA 926241A ZA 926241 B ZA926241 B ZA 926241B
- Authority
- ZA
- South Africa
- Prior art keywords
- dosage form
- short
- time period
- delivering drug
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/747,899 US5178867A (en) | 1991-08-19 | 1991-08-19 | Dosage form for delivering drug in short-time period |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA926241B true ZA926241B (en) | 1993-10-04 |
Family
ID=25007151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA926241A ZA926241B (en) | 1991-08-19 | 1992-08-19 | Dosage form for delivering drug in short-time period |
Country Status (17)
Country | Link |
---|---|
US (1) | US5178867A (xx) |
EP (1) | EP0600033B1 (xx) |
JP (1) | JP2934505B2 (xx) |
AT (1) | ATE129404T1 (xx) |
AU (1) | AU666674B2 (xx) |
CA (1) | CA2112679C (xx) |
DE (1) | DE69205687T2 (xx) |
DK (1) | DK0600033T3 (xx) |
ES (1) | ES2079206T3 (xx) |
FI (1) | FI940787A0 (xx) |
GR (1) | GR3017891T3 (xx) |
MX (1) | MX9204776A (xx) |
NO (1) | NO940376D0 (xx) |
NZ (1) | NZ244009A (xx) |
PT (1) | PT100789A (xx) |
WO (1) | WO1993003711A1 (xx) |
ZA (1) | ZA926241B (xx) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
DE69429119T2 (de) * | 1993-07-09 | 2002-07-18 | R.P. Scherer Corp., Troy | Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen |
US5536505A (en) * | 1993-12-15 | 1996-07-16 | Eastman Chemical Company | Controlled release matrix system using cellulose acetate/poly-2-ethyl-2-oxazoline blends |
US5523095A (en) * | 1993-12-15 | 1996-06-04 | Eastman Chemical Company | Controlled release matrix system using cellulose acetate/polyvinylpyrrolidone blends |
TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
DE69631981T2 (de) * | 1995-09-21 | 2005-04-14 | Pharma Pass Ii Llc, Irvine | Lansoprazolhaltige Arzneizusammensetzung und Herstellungsverfahren |
JP2001524131A (ja) * | 1997-05-09 | 2001-11-27 | セイジ、ファーマスーティカルズ、インク | 安定な経口医薬品剤形 |
DE19747261A1 (de) * | 1997-10-25 | 1999-04-29 | Bayer Ag | Osmotisches Arzneimittelfreisetzungssystem |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6099859A (en) * | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
ZA9810765B (en) * | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
US6524620B2 (en) | 1998-07-20 | 2003-02-25 | Andrx Pharmaceuticals, Inc. | Diltiazem controlled release formulation and method of manufacture |
US7094426B2 (en) * | 1998-08-27 | 2006-08-22 | Sage Pharmaceuticals, Inc. | Stable oral pharmaceutical dosage forms |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6099862A (en) * | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6780880B1 (en) * | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
US6326384B1 (en) * | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
FR2797767B1 (fr) * | 1999-08-27 | 2002-06-14 | Centre Nat Rech Scient | Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances |
US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
US20060153914A1 (en) * | 1999-12-10 | 2006-07-13 | Biovail Laboratories International S.R.L. | Chronotherapeutic diltiazem formulations and the administration thereof |
JP2003518487A (ja) | 1999-12-23 | 2003-06-10 | ファイザー・プロダクツ・インク | ヒドロゲル駆動型積層薬物製剤 |
US6669954B2 (en) | 2000-01-25 | 2003-12-30 | John R. Crison | Controlled release of drugs |
US6866866B1 (en) * | 2000-11-03 | 2005-03-15 | Andrx Labs, Llc | Controlled release metformin compositions |
US6790459B1 (en) | 2000-11-03 | 2004-09-14 | Andrx Labs, Llc | Methods for treating diabetes via administration of controlled release metformin |
MXPA03003994A (es) | 2000-11-03 | 2004-09-10 | Andrx Labs Llc | Composiciones de metformina de liberacion controlada. |
US20060034922A1 (en) * | 2000-11-03 | 2006-02-16 | Andrx Labs, Llc | Controlled release metformin compositions |
WO2003099214A2 (en) * | 2002-05-23 | 2003-12-04 | Andrx Corporation | Biguanide formulations |
US20040005359A1 (en) * | 2002-06-27 | 2004-01-08 | Cheng Xiu Xiu | Controlled release oral dosage form |
KR20120034211A (ko) | 2002-09-20 | 2012-04-10 | 안드렉스 랩스 엘엘씨 | 약제학적 정제 |
US20050051922A1 (en) * | 2002-09-20 | 2005-03-10 | Avinash Nangia | Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same |
US20040166162A1 (en) * | 2003-01-24 | 2004-08-26 | Robert Niecestro | Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
US7051606B2 (en) * | 2004-01-30 | 2006-05-30 | Andrx Labs Llc | Dosage form holder device and methods for immersion testing |
JP5563735B2 (ja) | 2004-06-16 | 2014-07-30 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | Ppi多回剤形 |
US20050287185A1 (en) * | 2004-06-23 | 2005-12-29 | David Wong | Extended release oxybutynin formulation |
US20070287740A1 (en) * | 2005-05-25 | 2007-12-13 | Transcept Pharmaceuticals, Inc. | Compositions and methods of treating middle-of-the night insomnia |
US20070225322A1 (en) * | 2005-05-25 | 2007-09-27 | Transoral Pharmaceuticals, Inc. | Compositions and methods for treating middle-of-the night insomnia |
US8242131B2 (en) * | 2005-05-25 | 2012-08-14 | Transcept Pharmaceuticals, Inc. | Methods of treating middle-of-the-night insomnia |
DE102005031577A1 (de) | 2005-07-06 | 2007-01-11 | Bayer Healthcare Ag | Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten |
CA2629740A1 (en) * | 2005-11-18 | 2007-06-14 | Synthon B.V. | Zolpidem tablets |
US8173158B2 (en) * | 2007-10-12 | 2012-05-08 | Takeda Pharmaceuticals U.S.A., Inc. | Methods of treating gastrointestinal disorders independent of the intake of food |
DE102008059206A1 (de) | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum |
AU2013258273A1 (en) | 2012-05-07 | 2014-11-13 | Bayer Pharma Aktiengesellschaft | Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil |
JP2023553202A (ja) | 2020-12-08 | 2023-12-20 | ルミナント バイオテク コーポレーション リミテッド | 動物に物質を送達するための装置および方法の改善 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2799241A (en) * | 1949-01-21 | 1957-07-16 | Wisconsin Alumni Res Found | Means for applying coatings to tablets or the like |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4063064A (en) * | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4519801A (en) | 1982-07-12 | 1985-05-28 | Alza Corporation | Osmotic device with wall comprising cellulose ether and permeability enhancer |
US4576604A (en) * | 1983-03-04 | 1986-03-18 | Alza Corporation | Osmotic system with instant drug availability |
US4783337A (en) * | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
US4612008A (en) * | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
US4693895A (en) * | 1984-10-26 | 1987-09-15 | Alza Corporation | Colon delivery system |
US4608048A (en) * | 1984-12-06 | 1986-08-26 | Alza Corporation | Dispensing device with drug delivery patterns |
ES2019634B3 (es) * | 1986-04-17 | 1991-07-01 | Alza Corp | Terapia con clorfeniramina. |
US4948592A (en) * | 1986-05-09 | 1990-08-14 | Alza Corporation | Pulsed drug delivery |
US4801461A (en) * | 1987-01-28 | 1989-01-31 | Alza Corporation | Pseudoephedrine dosage form |
NZ226822A (en) * | 1987-11-16 | 1990-03-27 | Mcneil Consumer Prod | Chewable medicament tablet containing means for taste masking |
US4931285A (en) * | 1988-04-28 | 1990-06-05 | Alza Corporation | Aqueous based pharmaceutical coating composition for dosage forms |
-
1991
- 1991-08-19 US US07/747,899 patent/US5178867A/en not_active Expired - Lifetime
-
1992
- 1992-08-18 MX MX9204776A patent/MX9204776A/es active IP Right Grant
- 1992-08-19 JP JP5504590A patent/JP2934505B2/ja not_active Expired - Fee Related
- 1992-08-19 ZA ZA926241A patent/ZA926241B/xx unknown
- 1992-08-19 WO PCT/US1992/007034 patent/WO1993003711A1/en active IP Right Grant
- 1992-08-19 AT AT92919273T patent/ATE129404T1/de not_active IP Right Cessation
- 1992-08-19 DK DK92919273.0T patent/DK0600033T3/da active
- 1992-08-19 DE DE69205687T patent/DE69205687T2/de not_active Expired - Fee Related
- 1992-08-19 EP EP92919273A patent/EP0600033B1/en not_active Expired - Lifetime
- 1992-08-19 ES ES92919273T patent/ES2079206T3/es not_active Expired - Lifetime
- 1992-08-19 NZ NZ244009A patent/NZ244009A/en unknown
- 1992-08-19 AU AU25449/92A patent/AU666674B2/en not_active Ceased
- 1992-08-19 CA CA002112679A patent/CA2112679C/en not_active Expired - Fee Related
- 1992-08-19 PT PT100789A patent/PT100789A/pt not_active Application Discontinuation
-
1994
- 1994-02-07 NO NO940376A patent/NO940376D0/no unknown
- 1994-02-18 FI FI940787A patent/FI940787A0/fi not_active Application Discontinuation
-
1995
- 1995-10-26 GR GR950402687T patent/GR3017891T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE129404T1 (de) | 1995-11-15 |
FI940787A (fi) | 1994-02-18 |
JPH06509809A (ja) | 1994-11-02 |
FI940787A0 (fi) | 1994-02-18 |
WO1993003711A1 (en) | 1993-03-04 |
ES2079206T3 (es) | 1996-01-01 |
DE69205687T2 (de) | 1996-04-11 |
DK0600033T3 (da) | 1995-12-27 |
EP0600033B1 (en) | 1995-10-25 |
DE69205687D1 (de) | 1995-11-30 |
NO940376L (no) | 1994-02-07 |
GR3017891T3 (en) | 1996-01-31 |
MX9204776A (es) | 1993-04-01 |
EP0600033A1 (en) | 1994-06-08 |
AU666674B2 (en) | 1996-02-22 |
NO940376D0 (no) | 1994-02-07 |
CA2112679A1 (en) | 1993-03-04 |
JP2934505B2 (ja) | 1999-08-16 |
PT100789A (pt) | 1994-05-31 |
US5178867A (en) | 1993-01-12 |
AU2544992A (en) | 1993-03-16 |
NZ244009A (en) | 1995-02-24 |
CA2112679C (en) | 2003-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3017891T3 (en) | Dosage form for delivering drug in short-time period. | |
EP0494972A4 (en) | Effervescent dosage form and method of administering same | |
ZA924772B (en) | Delayed therapy | |
WO1994027589A3 (en) | Antidepressant dosage form | |
EP0745401A3 (en) | Medication inhaler | |
MX173300B (es) | Mejoras en forma de dosis para suministrar droga al intestino | |
GR3032207T3 (en) | 2-Bromomelatonin in the therapy of sleep disorders | |
EP0552256A4 (xx) | ||
GB9016789D0 (en) | Medicament administering devices | |
DE69212879D1 (de) | Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren | |
GR3015302T3 (en) | Pharmaceutical formulations for preventing drug tolerance. | |
ZA96576B (en) | Extended-release solid oral dosage forms of drugs having low solubility in water | |
EP0279887A3 (en) | Carnitine directed pharmaceutical agents and their use for the manufacture of a medicament for the treatment of muscle disorder | |
GR3035231T3 (en) | Use of sulodexide and of medicines containing it for the treatment of diabetic nephropathy. | |
GR1000419B (el) | Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου. | |
EP0438147A3 (en) | Pharmaceutical compositions and dosage forms for the oral administration of calcitonin | |
ZA925146B (en) | Pharmaceutical agent for treatment of withdrawal symptoms. | |
MY100780A (en) | Azumolene dosage form. | |
KR900009029A (ko) | 가축병 치료용 약물을 투여하는 장치 | |
IL88697A0 (en) | Oral dosage units for pharmaceuticals and their use and preparation | |
EP0624368A3 (en) | Use of a composition to stimulate glutathione synthesis for the manufacture of a medicament for the treatment of AID. | |
MD1609G2 (ro) | Metodă de tratament al stomatitei aftoase recidivante cronice | |
IT1267664B1 (it) | Composizione a base di fosfocreatina e suo uso farmaceutico | |
Češková et al. | Alternative therapeutic approaches to the treatment of acute phases of endogenous psychoses. | |
IT1271354B (it) | Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi |